Midatech and Immunotope Form Joint Venture, Syntara LLC, for the Development of Immune Therapies

Midatech Group Ltd., a global leader for the design, development, synthesis and manufacture of nanomedicines, and Immunotope Inc, a biotechnology company focused on the development of immunotherapy products, today announced the formation of a joint venture Syntara LLC, to develop antigen based products for immune therapies to treat chronic viral infections and certain cancers.

Nanomaterials in the construction industry and resulting health and safety issues

Tailing after emerging nanotechnology applications in biomedical and electronic industries, the construction industry recently started seeking out a way to advance conventional construction materials using a variety of manufactured nanomaterials. The use of nanotechnology materials and applications in the construction industry should be considered not only for enhancing material properties and functions but also in the context of energy conservation. This is a particularly important prospect since a high percentage of all energy used (e.g., 41% in the United States) is consumed by commercial buildings and residential houses by applications such as heating, lighting, and air conditioning. A recent review by scientists at Rice University has looked at the benefits of using nanomaterials in construction materials but also highlights the potentially harmful aspects of releasing nanomaterials into the environment.